Dear JDD readers and colleagues,
The global COVID-19 pandemic has greatly impacted our lives: how we gather and connect has changed to ensure the health and safety of our communities.
During this time, as researchers, health professionals, and scientists around the world collaborate to develop solutions to protect our global community, the JDD has committed to continuing to publish the latest research, updates, and information to help providers better serve patients.
To support community collaboration, the JDD has premiered an online blog where registered users may comment and connect with other dermatology professionals to share information and learn: www.jddonline.com/jdd-blog.
Additionally, stay up-to-date with the latest developments by following JDD on Facebook, Instagram, Twitter, and LinkedIn.
The JDD is committed to providing timely information pertaining to new methods, techniques, drug therapies and devices to our dedicated community of healthcare professionals.
We thank you for your continued support, and wish you all well.
Stay Connected
You May Also Like
Dermatology Roundup: Newly FDA-Approved Cheek Filler, Molluscum Contagiosum Trial Results, Eating Disorders & Acne Vulgaris
By Allison Sit The Food and Drug Administration has approved Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults older than 21. Approval of the new…
